You have been asking for the Long-term data on Alemtuzumab. No doubt ProfG will post on this newly published data from Cambridge with followup for up to 12 years, good news but its not all good
Okay you win, my interest is peaked!!! What's the good news, but more importantly whats the not good news, was there progression to secondary progressive on people started earlier?!
Could you post the link to the article please?
Great results! But the proportion of secondary autoimmunity is frightening…
can you give a reference please?
Okay you win, my interest is peaked!!! What's the good news, but more importantly whats the not good news, was there progression to secondary progressive on people started earlier?!